Somanetics (SMTS) Director Henry Buys 22.6K Shares
More News related to SMTS
- Somanetics Corporation to Present at Noble Financial Equity Conference
- Citi Downgrades Somanetics (SMTS) to Hold
- Somanetics (SMTS) Announces Share Repurchase Program Increased By $15 Million
- Somanetics Announces Share Repurchase Program Increased By $15 Million
- Somanetics (SMTS) Tops Q2 View; Reaffirms FY08 Sales Guidance
Somanetics Corp. (Nasdaq: SMTS) Director, Robert Henry, bought 22,600 shares from 03/27-03/28 at prices from $14.94-$15.25, bringing his stake to 340,300 shares.
Somanetics Corporation engages in the development, manufacture, and marketing of medical devices primarily in the United States. [LJ]
Related Categories
Insider TradesStocks Mentioned
-2.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
